ATCO

What ATCO does

ATCO Laboratories Limited is a privately held pharmaceutical manufacturer headquartered in Karachi, Pakistan, operating a cGMP-compliant production facility and ranked the 8th largest pharmaceutical manufacturer in Pakistan on a unit basis as of IMS Q2 2022. The company manufactures and markets more than 100 branded generic pharmaceutical products across 30+ therapeutic categories spanning oncology, dermatology, central nervous system, ophthalmology, cardiovascular, anti-diabetic, anti-infective, anti-malarial, respiratory, and pain management segments, in dosage forms including tablets, capsules, injections, syrups, suspensions, creams, ointments, ophthalmic solutions, and inhalation solutions. The company also operates a parallel cosmeceutical product line under consumer brands such as Acnes, Deep Heat, Betaderm, Hyderquin, Melas, and Skin Aqua.

The company's go-to-market is sales-led, distributing domestically through Pakistan's healthcare system including hospitals, clinics, and pharmacies, while exporting to more than 23 countries since 1992 through international pharmaceutical distribution partnerships. Revenue is generated through one-time product sales with quote-based pricing not publicly disclosed, and there is no evidence of public listing, institutional investment, parent-subsidiary structures, mergers and acquisitions, or leadership changes in the source data. ATCO self-reports growing faster than the Pakistan pharmaceutical industry average; however, absolute revenue, headcount trends, and ownership structure are not disclosed.

The operational platform is anchored by a cGMP-compliant manufacturing facility in Karachi's S.I.T.E. industrial area, with supporting functions in quality operations, regulatory affairs, warehouse, and pharmacovigilance. No AI/ML capabilities, digital platforms, APIs, or technology integrations are evident in the input data, positioning ATCO as a traditional pharmaceutical manufacturer rather than a technology-enabled health platform.

Name

ATCO

Legal name

ATCO Laboratories Limited

Website

https://atcolab.com

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

501–1,000 employees

Short description

ATCO Laboratories Limited is a Karachi-based, privately held pharmaceutical manufacturer ranking 8th largest in Pakistan by units, producing 100+ branded generic drugs across 30+ therapeutic categories for domestic distribution and export to 23 countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Dermatology & Aesthetics Pharmaceuticals (HLAIAAAK)

akta.pro secondary industries

Dermocosmetics & Medical-Grade Skincare (CRABAAAF), Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

Keywords

• Pharmaceutical manufacturing
• Generic medicines
• Oncology drugs
• Cosmeceutical products
• CGMP compliant facility

Headquarters

HQ city

Karachi

HQ country

Pakistan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from manufacturing and selling pharmaceutical products including tablets, capsules, injections, syrups, creams, and ointments across multiple therapeutic categories.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

ATCO Laboratories manufactures and markets a broad portfolio of branded generic pharmaceutical products across multiple dosage forms (tablets, capsules, syrups, injections, creams, ointments, ophthalmic solutions) and therapeutic areas including oncology, dermatology, CNS, cardiovascular, anti-infectives, ophthalmology, anti-diabetics, and pain management. The company also operates a cosmeceutical skincare line (Acnes, Skin Aqua, Deep Heat, Hydrophil). Products are produced at a state-of-the-art cGMP compliant facility in Karachi, Pakistan, and distributed domestically through healthcare providers and exported to more than 23 countries.

Product overview

ATCO Laboratories is a pharmaceutical company based in Karachi, Pakistan, operating one of the largest and most diversified portfolios in the country. The company manufactures and markets a comprehensive range of pharmaceutical products across multiple dosage forms (capsules, tablets, syrups, suspensions, injectables, topical creams and ointments, ophthalmic solutions, inhalation solutions, and cosmeceuticals) and therapeutic segments including dermatologicals (26+ products), oncology (15+ products), central nervous system (14+ products), ophthalmologicals (13+ products), pain management (10+ products), anti-diabetic (5+ products), anti-hypertensive (5+ products), and others. The portfolio includes branded generic medications for various conditions such as infections, cardiovascular diseases, metabolic disorders, respiratory conditions, and skin diseases, as well as a line of cosmeceutical products under the Acnes and Skin Aqua brands for skincare.

Differentiator

Problem solved

Functional benefit

Brands

• Acnes: Cosmeceutical skincare product line
• Betaderm
• Deep Heat

Products and services

• A-Fantrine Anti-malarial tablet containing Artemether + Lumefantrine for treating malaria, marketed to healthcare providers and patients through pharmaceutical distribution channels.
• A-Fantrine Injection Anti-malarial injection containing Artemether for malaria treatment, supplied to hospitals and clinics.
• A-Glip Anti-diabetic tablet containing Sitagliptin for managing type 2 diabetes, prescribed through physicians and dispensed at pharmacies.
• Acdermin Dermatological product containing Clindamycin Phosphate + Tretinoin for acne treatment, distributed through dermatologists and pharmacies.
• Acnes C10 Cosmeceutical Vitamin C 10% serum for skin brightening and anti-aging, sold through pharmacies and skincare retail channels.
• Acnes Creamy Wash Facial cleanser containing Isopropylmethylphenol + Vitamins for acne-prone skin, sold through retail and pharmacy channels.
• Acnes Fairness Wash Facial wash product for skin fairness and brightening, marketed as part of the Acnes cosmeceutical line.
• Acnes Scar Care Scar treatment product containing Beta Carotene + Salicylic Acid + Ascorbic Acid + Isopropylmethylphenol.
• Acnes Vitamin Wash Facial wash containing Vitamin B3, B5, C and E for skin nourishment.
• Acsolve Topical solution containing Clindamycin for acne treatment, prescribed by dermatologists.
• Adapco Topical treatment containing Adapalene for acne vulgaris, supplied through dermatology channels.
• Addfer Iron supplement containing Iron hydroxide polymaltose for iron deficiency anemia.
• Adrim Oncology medication containing Doxorubicin Hydrochloride for cancer treatment, supplied to oncology hospitals and clinics.
• Advacort Corticosteroid containing Methylprednisolone Aceponate for inflammatory skin conditions.
• Aggrastat Antiplatelet agent containing Tirofiban HCl for acute coronary syndrome, distributed to cardiac care hospitals.
• Anthracin Oncology medication containing Epirubicin for various cancers, supplied to oncology treatment centers.
• Anxit Benzodiazepine containing Bromazepam for anxiety disorders, prescribed by psychiatrists and dispensed through pharmacies.
• Ascard Antiplatelet tablet containing Acetylsalicylic Acid for cardiovascular protection.
• Ascard Plus Antiplatelet combination containing Acetylsalicylic Acid + Clopidogrel for cardiovascular protection.
• Atcam Rapid Action NSAID containing Lornoxicam for pain and inflammation.
• Atcoflox Antibiotic containing Levofloxacin for bacterial infections, distributed through hospital and retail pharmacy channels.
• Atcomid Anticonvulsant containing Lacosamide for epilepsy.
• Atconate Bisphosphonate containing Risedronate Sodium for osteoporosis.
• Atcopram Antidepressant containing Escitalopram for depression and anxiety.
• Avanep Ophthalmic solution containing Nepafenac for eye inflammation, distributed to ophthalmologists and pharmacies.
• Avotrexid Antibiotic containing Linezolid for serious bacterial infections, supplied to hospitals.
• Betaderm Topical corticosteroid containing Betamethasone Valerate for skin inflammation.
• Betaderm N Topical corticosteroid with antibiotic containing Betamethasone Valerate + Neomycin Sulphate for infected skin inflammation.
• Betaderm NM Topical corticosteroid with antifungal and antibiotic containing Betamethasone Valerate + Neomycin Sulphate + Miconazole Nitrate.
• Betagenic Topical corticosteroid with antibiotic containing Betamethasone Dipropionate + Gentamicin.
• Betasalic Topical corticosteroid containing Betamethasone Dipropionate + Salicylic Acid for psoriasis.
• Bracin Ophthalmic antibiotic containing Tobramycin for eye infections.
• Bracin-D Ophthalmic combination containing Tobramycin + Dexamethasone for infected eye inflammation.
• Brimo-T Ophthalmic combination containing Brimonidine Tartrate + Timolol Maleate for glaucoma.
• Bronkal Bronchodilator containing Salbutamol for asthma and COPD, supplied through respiratory care channels.
• Bunorfin Opioid analgesic containing Buprenorphine for pain management, distributed to pain clinics and hospitals.
• Bynevol Beta-blocker containing Nebivolol for hypertension.
• C-Off Antiviral containing Sofosbuvir for Hepatitis C treatment.
• Cardnit Nitrate containing Glyceryl Trinitrate for angina, supplied to cardiac care providers.
• Clobederm High-potency topical corticosteroid containing Clobetasol Propionate for severe inflammatory skin conditions.
• Clobederm NN Topical corticosteroid with antifungal and antibiotic containing Clobetasol Propionate + Nystatin + Neomycin Sulphate.
• Clobederm-S Topical corticosteroid containing Clobetasole Propionate + Salicylic Acid for hyperkeratotic conditions.
• Clonexa Sleep aid containing Eszopiclone for insomnia.
• Coagurin Anticoagulant containing Warfarin for thromboembolic disorders.
• Combinol H Junior Herbal cough remedy containing Ivy Leaf Extract for children's cough.
• Combinol H Plus Herbal cough remedy containing Ivy Leaf Extract + Combination of Herbs.
• Combinol Junior Pediatric cough syrup containing Promethazine HCL + Pholcodine.
• Combinol-D Cough suppressant containing Dextromethorphan Compound.
• Combinol-E Bronchodilator combination containing Aminophylline Compound.
• Conaz Antifungal containing Ketoconazole for skin and systemic fungal infections.
• Cytarine Oncology medication containing Cytarabin for leukemia treatment.
• D-All Vitamin D3 supplement containing Cholecalciferol for bone health.
• Daxotel Oncology medication containing Docetaxel for breast, lung, and prostate cancers.
• Decapeptyl GnRH analog containing Triptorelin Acetate for prostate cancer and endometriosis.
• Deep Heat (regular) Topical analgesic balm for muscle and joint pain relief, sold as a cosmeceutical/OTC product.
• Depilus Topical depilatory containing Eflornithine Hydrochloride for unwanted facial hair.
• Diarox Anti-inflammatory for osteoarthritis containing Diacerein.
• Dioplus Combination antihypertensive containing Amlodipine Besilate + Valsartan for hypertension.
• Distalgesic Combination analgesic containing Tramadol Hydrochloride + Paracetamol for pain management.
• Donecept Cholinesterase inhibitor containing Donepezil HCl for Alzheimer's disease.
• Doxyn Antibiotic containing Doxycycline Hyclate for various bacterial infections.
• Ecorox Proton pump inhibitor containing Esomeprazole for acid-related gastrointestinal disorders.
• Elantan Nitrate containing Isosorbide Mononitrate for angina prevention.
• Epigran Anticonvulsant containing Phenytoin Sodium for epilepsy.
• Eumytic Muscle relaxant containing Cyclobenzaprine HCl for musculoskeletal pain.
• Femizet Aromatase inhibitor containing Anastrozole for breast cancer treatment.
• Fixicef Antibiotic containing Cefixime for urinary tract and respiratory infections.
• Flurozine Ophthalmic solution containing Fluorometholone + Tetryzoline HCl for eye allergies.
• Fytosid Oncology medication containing Etoposide for various cancers.
• Gemita Oncology medication containing Gemcitabine for pancreatic, lung, and bladder cancers.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Getz Pharma: Pakistan-based branded-generic manufacturer with a similarly broad multi-therapeutic portfolio (cardio, diabetes, dermatology, oncology) sold domestically and exported; directly competes with ATCO across nearly the same therapeutic segments and channels.
• Ferozsons Laboratories: Listed Pakistani pharma manufacturer with branded generics, specialty pharma, and a partnership with Gilead for hepatitis treatments; comparable to ATCO as a multi-category domestic manufacturer with export reach.
• Hilton Pharma: Pakistani pharmaceutical company producing branded generics across multiple therapeutic areas including dermatology and cardiology; directly comparable mid-tier local manufacturer competing for the same physicians, pharmacies, and hospital channels as ATCO.
• Sami Pharmaceuticals: Pakistan-based pharma manufacturer with a branded-generic portfolio spanning several therapeutic categories, including cardiovascular and CNS; competes with ATCO domestically and in select international markets.
• PharmEvo (Pakistan): Pakistani pharmaceutical manufacturer with a broad branded-generic portfolio across chronic and acute therapeutic categories; competes with ATCO for share in the domestic market and is similarly export-oriented in South Asia and emerging markets.
• Searle Company (Pakistan): Karachi-headquartered pharma company manufacturing branded generics in cardiovascular, central nervous system, dermatology, and consumer health; competes directly with ATCO in the domestic Pakistani market and selected export geographies.

Broad incumbents

• Sandoz (Novartis division): Global leader in off-patent branded and generic pharmaceuticals including oncology, dermatology, and ophthalmology — areas where ATCO has a meaningful presence; relevant for benchmarking exposure to generics price dynamics and global expansion paths.
• Abbott Laboratories Pakistan: Subsidiary of a global diversified healthcare company with broad pharmaceutical, nutrition, and diagnostics offerings in Pakistan; overlaps with ATCO in branded generics and consumer health, though as part of a much larger global portfolio.
• GlaxoSmithKline Pakistan: Subsidiary of a global pharma major operating in Pakistan with a broad pharmaceutical and consumer healthcare portfolio; serves as an incumbent competitor to ATCO across most therapeutic categories in the local market.

Emerging players

• Amson Vaccines and Pharma: Pakistan-based pharmaceutical manufacturer focused on vaccines and select specialty therapeutic areas; less diversified than ATCO but increasingly relevant in adjacent biologic and specialty segments.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights8 records

Customer concentration

• Facebookfacebook.com/atcolaboratoriesltd

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about ATCO